SCHEMBL16085428

SCHEMBL16085428

O=C(Nc1ncc(Cc2ccc(C(F)(F)F)cc2)s1)c1ccnc(-c2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.57
▸ MEN1 O00255 3/20 0.57
▸ KMT2A Q03164 3/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ HPGD P15428 1/20 0.57
▸ SCD O00767 13/20 0.56
▸ MAPT P10636 2/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ ABL1 P00519 2/20 0.52
▸ KDM1A O60341 1/20 0.51
▸ HDAC1 Q13547 1/20 0.51
▸ NPC1 O15118 2/20 0.50
▸ TP53 P04637 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ NFKB1 P19838 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ NFKB2 Q00653 1/20 0.50
▸ RELA Q04206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16085425 0.89 SCD (0.61) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085525 0.85 LMNA (0.53) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085539 0.85 LMNA (0.57) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085613 0.84 SCD (0.55) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085610 0.82 SCD (0.65) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085429 0.82 LMNA (0.56) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085488 0.81 MEN1 (0.61) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085404 0.81 KMT2A (0.74) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085570 0.81 ABL1 (0.59) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL16085487 0.80 ABL1 (0.60) LMNAMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014145642-A9 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2014-11-13 — — WO disclosed
WO-2014145642-A2 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY THE JOHNS HOPKINS UNIVERSITY (US) 2014-09-18 — — WO disclosed
US-8728631-B2 Dendrimer compound and organic luminescent device employing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2014-05-20 — — US disclosed
Send feedback